Evidence map›Paper›PMID 38661343›Full record

ArticlemSphere2024

The loss of the PDIM/PGL virulence lipids causes differential secretion of ESX-1 substrates in

Bradley S Jones, Daniel D Hu, Kathleen R Nicholson, Rachel M Cronin, Simon D Weaver, Matthew M Champion, Patricia A Champion

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Tyloxapol inhibits ESX-1 secretion inJournal of bacteriology · 2026
    Article
  3. Article
  4. PDIM/PGL-deficientMicrobiology resource announcements · 2026
    Article
  5. NProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Journal of bacteriology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bradley S Jones *Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Daniel D Hu *Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Kathleen R NicholsonDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Rachel M CroninDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Simon D WeaverDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Matthew M ChampionEck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0001-5927-5277
Patricia A ChampionDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0002-6733-596X
University of Notre Dame · US

Funding

Role of N-alpha acetylation in mycobacterial secretion and virulenceR01AI106872 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2013 to 2024
$4.2M
Chemistry-Biochemistry-Biology Training Program at Notre DameT32GM075762 · NIGMS · UNIVERSITY OF NOTRE DAME · PI CHANG, MAYLAND F, MOBASHERY, SHAHRIAR · 2007 to 2021
$3.7M
Systematic Discovery and Analysis of Small Proteins and Small ORFs in MycobacteriaR01GM139277 · NIGMS · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, GRAY, TODD · 2020 to 2023
$2.2M
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre DameT32GM145773 · NIGMS · UNIVERSITY OF NOTRE DAME · PI Christian Corey Melander · 2022 to 2026
$1.5M
Dissecting and connecting the SigM stimulus and ESX-4 secretory response in mycobacteriaR01GM144372 · NIGMS · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, GRAY, TODD · 2022 to 2023
$771k
Investigating the molecular requirements for ESX-1-lytic activity in pathogenic mycobacteriaR21AI156229 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2021 to 2022
$430k
Mechanisms of ESX-1-dependent Gene Expression in Pathogenic MycobacteriaR21AI149235 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2020 to 2021
$425k
The requirement for PDIM in mycobacterial protein secretionR03AI149147 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2020 to 2021
$156k
NIAID NIH HHS R01 AI106872NIAID NIH HHS R03 AI149147NIAID NIH HHS R21 AI149235NIAID NIH HHS R21 AI156229NIGMS NIH HHS R01 GM139277NIGMS NIH HHS R01 GM144372NIGMS NIH HHS T32 GM075762NIGMS NIH HHS T32 GM145773
6 · The paper itself

Abstract

The mycobacterial cell envelope is a major virulence determinant in pathogenic mycobacteria. Specific outer lipids play roles in pathogenesis, modulating the immune system and promoting the secretion of virulence factors. ESX-1 (ESAT-6 system-1) is a conserved protein secretion system required for mycobacterial pathogenesis. Previous studies revealed that mycobacterial strains lacking the outer lipid PDIM have impaired ESX-1 function during laboratory growth and infection. The mechanisms underlying changes in ESX-1 function are unknown. We used a proteo-genetic approach to measure phthiocerol dimycocerosate (PDIM)- and phenolic glycolipid (PGL)-dependent protein secretion in

Indexed as

Bacterial ProteinsGlycolipidsMycobacterium marinumVirulence FactorsAntigens, BacterialLipidsVirulenceAntigens, BacterialBacterial ProteinsGlycolipidsLipidsphthiocerol dimycocerosateVirulence FactorsESX-1MycobacteriumPDIMproteomicssecretion

Identifiers

PMID38661343
PMCPMC11237470
OpenAlexW4395465265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.